Copyright Reports & Markets. All rights reserved.

Global Femoral Stems Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Femoral Stems Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Femoral Stems Market Size Growth Rate by Product
      • 1.4.2 Cementless
      • 1.4.3 Cemented
      • 1.4.4 Cemented or Non-cemented
    • 1.5 Market by End User
      • 1.5.1 Global Femoral Stems Market Size Growth Rate by End User
      • 1.5.2 Primary Surgical
      • 1.5.3 Revision Surgical
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Femoral Stems Market Size
      • 2.1.1 Global Femoral Stems Revenue 2014-2025
      • 2.1.2 Global Femoral Stems Sales 2014-2025
    • 2.2 Femoral Stems Growth Rate by Regions
      • 2.2.1 Global Femoral Stems Sales by Regions
      • 2.2.2 Global Femoral Stems Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Femoral Stems Sales by Manufacturers
      • 3.1.1 Femoral Stems Sales by Manufacturers
      • 3.1.2 Femoral Stems Sales Market Share by Manufacturers
      • 3.1.3 Global Femoral Stems Market Concentration Ratio (CR5 and HHI)
    • 3.2 Femoral Stems Revenue by Manufacturers
      • 3.2.1 Femoral Stems Revenue by Manufacturers (2014-2019)
      • 3.2.2 Femoral Stems Revenue Share by Manufacturers (2014-2019)
    • 3.3 Femoral Stems Price by Manufacturers
    • 3.4 Femoral Stems Manufacturing Base Distribution, Product Types
      • 3.4.1 Femoral Stems Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Femoral Stems Product Type
      • 3.4.3 Date of International Manufacturers Enter into Femoral Stems Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Femoral Stems Sales by Product
    • 4.2 Global Femoral Stems Revenue by Product
    • 4.3 Femoral Stems Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Femoral Stems Breakdown Data by End User

    6 North America

    • 6.1 North America Femoral Stems by Countries
      • 6.1.1 North America Femoral Stems Sales by Countries
      • 6.1.2 North America Femoral Stems Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Femoral Stems by Product
    • 6.3 North America Femoral Stems by End User

    7 Europe

    • 7.1 Europe Femoral Stems by Countries
      • 7.1.1 Europe Femoral Stems Sales by Countries
      • 7.1.2 Europe Femoral Stems Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Femoral Stems by Product
    • 7.3 Europe Femoral Stems by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Femoral Stems by Countries
      • 8.1.1 Asia Pacific Femoral Stems Sales by Countries
      • 8.1.2 Asia Pacific Femoral Stems Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Femoral Stems by Product
    • 8.3 Asia Pacific Femoral Stems by End User

    9 Central & South America

    • 9.1 Central & South America Femoral Stems by Countries
      • 9.1.1 Central & South America Femoral Stems Sales by Countries
      • 9.1.2 Central & South America Femoral Stems Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Femoral Stems by Product
    • 9.3 Central & South America Femoral Stems by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Femoral Stems by Countries
      • 10.1.1 Middle East and Africa Femoral Stems Sales by Countries
      • 10.1.2 Middle East and Africa Femoral Stems Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Femoral Stems by Product
    • 10.3 Middle East and Africa Femoral Stems by End User

    11 Company Profiles

    • 11.1 Aesculap
      • 11.1.1 Aesculap Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Aesculap Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Aesculap Femoral Stems Products Offered
      • 11.1.5 Aesculap Recent Development
    • 11.2 Altimed
      • 11.2.1 Altimed Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Altimed Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Altimed Femoral Stems Products Offered
      • 11.2.5 Altimed Recent Development
    • 11.3 ARZZT
      • 11.3.1 ARZZT Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 ARZZT Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 ARZZT Femoral Stems Products Offered
      • 11.3.5 ARZZT Recent Development
    • 11.4 Beijing Chunli Technology Development
      • 11.4.1 Beijing Chunli Technology Development Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Beijing Chunli Technology Development Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Beijing Chunli Technology Development Femoral Stems Products Offered
      • 11.4.5 Beijing Chunli Technology Development Recent Development
    • 11.5 Beznoska
      • 11.5.1 Beznoska Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Beznoska Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Beznoska Femoral Stems Products Offered
      • 11.5.5 Beznoska Recent Development
    • 11.6 Biomet
      • 11.6.1 Biomet Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Biomet Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Biomet Femoral Stems Products Offered
      • 11.6.5 Biomet Recent Development
    • 11.7 Biotech Medical
      • 11.7.1 Biotech Medical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Biotech Medical Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Biotech Medical Femoral Stems Products Offered
      • 11.7.5 Biotech Medical Recent Development
    • 11.8 Biotechni
      • 11.8.1 Biotechni Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Biotechni Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Biotechni Femoral Stems Products Offered
      • 11.8.5 Biotechni Recent Development
    • 11.9 C2F Implants
      • 11.9.1 C2F Implants Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 C2F Implants Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 C2F Implants Femoral Stems Products Offered
      • 11.9.5 C2F Implants Recent Development
    • 11.10 Corentec
      • 11.10.1 Corentec Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Corentec Femoral Stems Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Corentec Femoral Stems Products Offered
      • 11.10.5 Corentec Recent Development
    • 11.11 Depuy Synthes
    • 11.12 Evolutis
    • 11.13 Exactech
    • 11.14 FH Orthopedics
    • 11.15 Groupe Lepine
    • 11.16 IMECO SA
    • 11.17 ImplanTec

    12 Future Forecast

    • 12.1 Femoral Stems Market Forecast by Regions
      • 12.1.1 Global Femoral Stems Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Femoral Stems Revenue Forecast by Regions 2019-2025
    • 12.2 Femoral Stems Market Forecast by Product
      • 12.2.1 Global Femoral Stems Sales Forecast by Product 2019-2025
      • 12.2.2 Global Femoral Stems Revenue Forecast by Product 2019-2025
    • 12.3 Femoral Stems Market Forecast by End User
    • 12.4 North America Femoral Stems Forecast
    • 12.5 Europe Femoral Stems Forecast
    • 12.6 Asia Pacific Femoral Stems Forecast
    • 12.7 Central & South America Femoral Stems Forecast
    • 12.8 Middle East and Africa Femoral Stems Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Femoral Stems Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Femoral Stems market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Femoral Stems market based on company, product type, end user and key regions.

      This report studies the global market size of Femoral Stems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Femoral Stems in these regions.
      This research report categorizes the global Femoral Stems market by top players/brands, region, type and end user. This report also studies the global Femoral Stems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Aesculap
      Altimed
      ARZZT
      Beijing Chunli Technology Development
      Beznoska
      Biomet
      Biotech Medical
      Biotechni
      C2F Implants
      Corentec
      Depuy Synthes
      Evolutis
      Exactech
      FH Orthopedics
      Groupe Lepine
      IMECO SA
      ImplanTec

      Market size by Product
      Cementless
      Cemented
      Cemented or Non-cemented
      Market size by End User
      Primary Surgical
      Revision Surgical

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Femoral Stems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Femoral Stems market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Femoral Stems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Femoral Stems submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Femoral Stems are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Femoral Stems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now